Jindal Stainless Limited (JSL) reported a steady Q3 FY26 with standalone Net Profit rising to ₹665.85 crore from ₹618.64 crore YoY. While revenue saw a marginal sequential decline to ₹10,632.35 crore, the company achieved an improvement in operating margins to 10.38% from 9.74% in the previous quarter. The board has declared an interim dividend of ₹1 per share (50% of face value) with a record date of January 29, 2026. Furthermore, the company continues to deleverage, with its debt-to-equity ratio improving to 0.24.

Jindal Stainless Limited (JSL) reported a steady Q3 FY26 performance with standalone Profit After Tax (PAT) rising to ₹665.85 crore, a 7.6% increase year-on-year. The company declared an interim dividend of ₹1 per share (50% of face value), with the record date fixed as January 29, 2026. While revenue saw a slight sequential dip to ₹10,632.35 crore, operating margins improved significantly to 10.38% from 9.74% in the previous quarter. The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.24x.

Jindal Stainless Limited (JSL) reported a steady performance for Q3 FY26 with a 7.6% YoY increase in net profit to ₹665.85 crore. Revenue from operations grew by 5.6% YoY to reach ₹10,632.35 crore, supported by improved operating margins of 10.38%. The board has declared an interim dividend of ₹1 per share (50% of face value) with a record date of January 29, 2026. Additionally, the company's debt-equity ratio improved significantly to 0.24 from 0.33 YoY, reflecting a stronger balance sheet.

Jeena Sikho Lifecare Limited (JSLL) has announced that its international subsidiary will acquire a 51% controlling stake in Abu Dhabi-based Back to Roots Ayurveda for AED 1.53 million. This acquisition marks a significant step in JSLL's global expansion strategy within the Ayurveda and wellness sector. The target entity has shown rapid growth, with turnover increasing from AED 0.77 million in 2024 to AED 2.5 million in 2025. The transaction is expected to be completed within 2-3 months via cash consideration, making it a step-down subsidiary of JSLL.

Jeena Sikho Lifecare Limited (JSLL) has entered into a procurement agreement with Theryco Healthcare Solutions Private Limited to enhance its digital presence. Under this agreement, dated January 3, 2026, Theryco is authorized to list, manage, and sell JSLL's products on the Amazon e-commerce platform. This strategic move is intended to strengthen the company's distribution reach and improve product availability across digital channels. The company has confirmed that the transaction is on an arm's length basis and does not involve any related parties.

Jeena Sikho Lifecare Limited (JSLL) has published two research articles in international journals validating its Ayurvedic treatment protocols for Type 2 Diabetes and Chronic Kidney Disease. A key case study highlighted a patient's HbA1c reduction from 7.3% to 6.4% and a significant recovery in pancreatic function, with fecal elastase increasing from 102 µg/g to 694 µg/g. The study also reported a 50% reduction in triglycerides, from 439 mg/dl to 220 mg/dl, and a decrease in total cholesterol from 217 mg/dl to 157 mg/dl. These publications support the company's commitment to evidence-based Ayurveda and clinical advancement.

Jindal Stainless Limited (JSL) has been assigned an ESG rating of 71 for the Financial Year 2024-25 by NSE Sustainability Ratings & Analytics. This rating is a result of the company's compliance with the updated SEBI guidelines for ESG disclosures by registered providers. A score of 71 reflects the company's commitment to environmental, social, and governance standards in the manufacturing sector. This standardized rating allows institutional investors to better assess the company's non-financial risk profile and sustainability performance.

India Ratings & Research has revised the credit rating outlook for Jindal Stainless Limited's long-term borrowings from 'Stable' to 'Positive' while affirming the rating at 'IND AA'. The agency also reaffirmed the company's short-term borrowing rating at 'IND A1+', which is the highest possible rating for short-term instruments. This outlook revision indicates a strengthening financial profile and the potential for a formal rating upgrade in the near future. Such improvements typically lead to lower interest costs and enhanced access to capital markets.

Jeena Sikho Lifecare Limited (JSLL) has successfully secured the National Accreditation Board for Hospitals & Healthcare Providers (NABH) certificate for its Sanganer Hospital in Rajasthan. The accreditation specifically covers Panchakarma services and is valid under certification number AH-2025-0412 until November 10, 2028. This certification validates the company's commitment to high standards of patient safety and quality healthcare delivery. Such accreditations are vital for healthcare providers to enhance brand reputation and facilitate empanelment with insurance providers.

Jeena Sikho Lifecare Limited (JSLL) has announced the publication of three academic case studies and reports in international journals focusing on Ayurvedic management of Chronic Kidney Disease (CKD). A key case study highlighted in the filing demonstrated significant clinical improvements in a 56-year-old patient, with serum urea dropping from 230.86 mg/dL to 117.39 mg/dL and creatinine reducing from 6.32 mg/dL to 5.17 mg/dL. The research validates the company's proprietary Ayurvedic formulations and specialized 'DIP' diet protocols. These publications are part of JSLL's strategy to establish evidence-based credibility for its clinical practices and hospital-based treatments.

Jindal Stainless Limited (JSL) has announced its ESG rating for the Financial Year 2024-25 as per SEBI's updated disclosure requirements. The company was assigned a score of 68.3 by SES ESG Research Private Limited, a SEBI-registered Category II ESG Rating Provider. This disclosure follows the SEBI circular dated November 11, 2024, emphasizing standardized ESG reporting for listed entities. The rating provides a benchmark for the company's sustainability and governance performance relative to its peers.

Jeena Sikho Lifecare Limited (JSLL) has successfully empanelled 44 of its Ayurveda Panchkarma Hospitals with Medsave Health Insurance TPA Limited. This strategic arrangement enables the company to provide cashless Ayurvedic treatments to insured beneficiaries across a wide network of locations. The empanelment covers major Indian cities including Mumbai, Delhi, Bangalore, Hyderabad, and Kolkata, significantly enhancing service accessibility. This move is expected to drive higher patient footfall and revenue by integrating traditional treatments with mainstream insurance coverage.

Jeena Sikho Lifecare Limited (JSLL) has announced the empanelment of its Ayurveda Panchkarma Hospitals with Medsave Health Insurance TPA Limited. This strategic move covers 44 hospital locations across India, enabling the company to provide cashless treatment to insured beneficiaries. By integrating with a major TPA, JSLL is likely to see an increase in patient footfall as Ayurvedic treatments become more accessible through insurance. This development aligns with the company's efforts to formalize and scale its healthcare service offerings across multiple states.

Jeena Sikho Lifecare Limited (JSLL) has announced the empanelment of 44 of its Ayurveda Panchkarma Hospitals with Medsave Health Insurance TPA Limited. This strategic move enables the company to provide cashless treatment to insured beneficiaries across a wide network of locations including major cities like Mumbai, Delhi, and Bangalore. By integrating with a TPA, JSLL is likely to see an increase in patient footfall from the insured segment, which has historically been a barrier for traditional Ayurvedic treatments. The empanelment is part of the company's ordinary course of business and aims to enhance service accessibility and revenue potential.

Jeena Sikho Lifecare Limited (JSLL) has announced the empanelment of 44 of its Ayurveda Panchkarma Hospitals with Medsave Health Insurance TPA Limited. This strategic partnership enables the company to offer cashless treatment to insured beneficiaries across a vast network of locations including Mumbai, Bangalore, Delhi, and Chennai. By integrating with a major TPA, JSLL is positioned to increase patient footfall and revenue from the insured demographic. The arrangement is conducted in the ordinary course of business and involves no related party transactions.

Jeena Sikho Lifecare Limited (JSLL) has announced a change in its internal audit function effective December 23, 2025. The company accepted the resignation of M/s Deepak K Garg & Associates, who cited pre-occupation with other professional commitments as the reason for leaving. In their place, the Board has appointed M/s Forvis Mazars LLP, a leading international assurance and advisory firm, for the financial year 2025-26. This transition to a global firm is typically seen as a move to strengthen internal controls and corporate governance.

Jindal Stainless has achieved an ESG score of 78 in the Dow Jones Sustainability Index (DJSI) Corporate Sustainability Assessment (CSA) for FY25, placing it among the top 5% of steel companies globally. The company ranks fourth in the steel sector and first in the stainless steel sector worldwide. Jindal Stainless' ESG scores are 83 in Environmental, 73 in Social, and 76 in Governance & Economic, exceeding the industry averages of 37, 35, and 36, respectively. The company also achieved a 14% year-on-year reduction in GHG emissions in FY25.